Taking stock of the drug industry, from the lab to the medicine chestApril 17, 2025Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Adobe STAT+ | Daily pill from Eli Lilly helps patients control blood sugar, lose weight, Phase 3 study shows Companies have been trying to develop pills that could offer the weight loss benefits that the currently available injectable drugs do. By Andrew Joseph and Elaine Chen STAT+ | GSK blood cancer therapy, once pulled from the market, is approved in the U.K. The therapy, which treats multiple myeloma, will be used in combination with other medicines. It is currently under review in other countries, including the U.S. By Andrew Joseph STAT+ | Arkansas adopts first-in-the-nation law forcing companies to choose between running a PBM or pharmacies The law prohibits PBMs from operating both retail and mail-order pharmacies, a move designed to eliminate a conflict of interest. By Ed Silverman Lexey Swall for STAT For an Air Force vet, an FDA layoff brings back symptoms of PTSD Moving from the military to a government job was the path to prosperity. Now, Karen Hollitt considers flipping burgers to feed her kids By Eric Boodman STAT+ | UnitedHealth cuts profit outlook by $3 billion as more Medicare patients get care The higher use of care among these Medicare enrollees "was most notable within physician and outpatient services," UnitedHealth said. By Bob Herman and Tara Bannow More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments